These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 18202183

  • 1. Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish.
    Asakawa K, Suster ML, Mizusawa K, Nagayoshi S, Kotani T, Urasaki A, Kishimoto Y, Hibi M, Kawakami K.
    Proc Natl Acad Sci U S A; 2008 Jan 29; 105(4):1255-60. PubMed ID: 18202183
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Analysis of genes and genome by the tol2-mediated gene and enhancer trap methods.
    Urasaki A, Kawakami K.
    Methods Mol Biol; 2009 Jan 29; 546():85-102. PubMed ID: 19378099
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell labeling and ablation in zebrafish.
    Davison JM, Akitake CM, Goll MG, Rhee JM, Gosse N, Baier H, Halpern ME, Leach SD, Parsons MJ.
    Dev Biol; 2007 Apr 15; 304(2):811-24. PubMed ID: 17335798
    [Abstract] [Full Text] [Related]

  • 7. Transgenesis in zebrafish with the tol2 transposon system.
    Suster ML, Kikuta H, Urasaki A, Asakawa K, Kawakami K.
    Methods Mol Biol; 2009 Apr 15; 561():41-63. PubMed ID: 19504063
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Establishment of Gal4 transgenic zebrafish lines for analysis of development of cerebellar neural circuitry.
    Takeuchi M, Matsuda K, Yamaguchi S, Asakawa K, Miyasaka N, Lal P, Yoshihara Y, Koga A, Kawakami K, Shimizu T, Hibi M.
    Dev Biol; 2015 Jan 01; 397(1):1-17. PubMed ID: 25300581
    [Abstract] [Full Text] [Related]

  • 13. Targeting neural circuitry in zebrafish using GAL4 enhancer trapping.
    Scott EK, Mason L, Arrenberg AB, Ziv L, Gosse NJ, Xiao T, Chi NC, Asakawa K, Kawakami K, Baier H.
    Nat Methods; 2007 Apr 01; 4(4):323-6. PubMed ID: 17369834
    [Abstract] [Full Text] [Related]

  • 14. Insertional mutagenesis by the Tol2 transposon-mediated enhancer trap approach generated mutations in two developmental genes: tcf7 and synembryn-like.
    Nagayoshi S, Hayashi E, Abe G, Osato N, Asakawa K, Urasaki A, Horikawa K, Ikeo K, Takeda H, Kawakami K.
    Development; 2008 Jan 01; 135(1):159-69. PubMed ID: 18065431
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gal4-based enhancer-trapping in the malaria mosquito Anopheles stephensi.
    O'Brochta DA, Pilitt KL, Harrell RA, Aluvihare C, Alford RT.
    G3 (Bethesda); 2012 Nov 01; 2(11):1305-15. PubMed ID: 23173082
    [Abstract] [Full Text] [Related]

  • 17. Tol2 transposon-mediated enhancer trap to identify developmentally regulated zebrafish genes in vivo.
    Parinov S, Kondrichin I, Korzh V, Emelyanov A.
    Dev Dyn; 2004 Oct 01; 231(2):449-59. PubMed ID: 15366023
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adaptation of GAL4 activators for GAL4 enhancer trapping in zebrafish.
    Ogura E, Okuda Y, Kondoh H, Kamachi Y.
    Dev Dyn; 2009 Mar 01; 238(3):641-55. PubMed ID: 19191223
    [Abstract] [Full Text] [Related]

  • 20. Zebrafish transgenic lines co-expressing a hybrid Gal4 activator and eGFP in tissue-restricted patterns.
    Gupta P, Zhao XF, Prat CR, Narawane S, Suh CS, Gharbi N, Ellingsen S, Fjose A.
    Gene Expr Patterns; 2011 Dec 01; 11(8):517-24. PubMed ID: 21930245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.